Invention Publication
- Patent Title: METHODS FOR TREATMENT OF RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA WITH MOSUNETUZUMAB AND LENALIDOMIDE
-
Application No.: US18050736Application Date: 2022-10-28
-
Publication No.: US20230190932A1Publication Date: 2023-06-22
- Inventor: Catherine GRANIER , Andrea Knapp , Chi-Chung Li , Carol Elaine O'Hear , Enkhtsetseg Purev , Michael C. Wei
- Applicant: Genentech, Inc. , Hoffmann-La Roche Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Genentech, Inc.,Hoffmann-La Roche Inc.
- Current Assignee: Genentech, Inc.,Hoffmann-La Roche Inc.
- Current Assignee Address: US CA South San Francisco
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K31/454 ; A61P35/00 ; A61P7/00
Abstract:
The present invention relates to the treatment of subjects having relapsed and/or refractory (R/R) follicular lymphoma (FL). More specifically, the invention pertains to the treatment of subjects having R/R FL by administering a combination of mosunetuzumab and lenalidomide.
Information query
